斑蝥素衍生物与铂络合物抗癌活性的实验研究  被引量:28

Experimental Study on Anti Cancer Effect of Cantharidine Derivatives and Platinum Complex

在线阅读下载全文

作  者:高倬[1,2] 姜平[1,2] 熊惠周 熊辛 陈光祥[1,2] 

机构地区:[1]昆明医学院第一附属医院肿瘤研究所 [2]云南省贵金属研究所

出  处:《中国中西医结合杂志》1999年第1期37-39,共3页Chinese Journal of Integrated Traditional and Western Medicine

基  金:国家自然科学基金

摘  要:目的:研究4种斑蝥素衍生物与铂络合物(斑铂,Dpt)对实验动物的抗癌作用,力图开发一种新型的铂族金属抗癌药。方法:以S180肉瘤、H22肝癌实体瘤及其腹水瘤小鼠为实验动物,通过腹腔或静脉给予不同剂量的4种化合物Dpt1-15、Dpt5-10、Dpt12-3、Dpt6-2,分别观察药物对小鼠瘤重及存活天数的影响,以顺铂为阳性对照,生理盐水为阴性对照。所有数据进行t检验。结果:4种斑铂(Dpt1-15、Dpt5-10、Dpt12-3、Dpt6-2)均有抗癌活性。其中Dpt5-10、Dpt1-15对小鼠S180肉瘤及H22实体瘤的抑制率与顺铂相似;Dpt5-10对H22腹水瘤小鼠生命延长率与顺铂相似;Dpt1-15的有效剂量毒性较大。结论:斑铂是有效的新型抗癌化合物,其中Dpt5-10抗癌作用较好,应进一步改进药物溶解性,并从与顺铂抗药性不同方面开发利用。Objective: To certify the anti tumor effects of the four Cantharidine derivatives and platinum complex on transplanted tumor in mice to search for new anti tumor drugs. Methods: Complex of four Cantharidine derivatives (Dpt 1-15, Dpt 5-10, Dpt 12-3 and Dpt6-2) and platinum were given to tumor beating mice of transplanted S 180 sarcoma, H 22 solid hepatocarcinoma and ascites hepatocarcinoma through intraperitoneal or intravenous injection, and the effect of treatment on tumor weight and survival of animal were observed. Cisplatin was used as positive control and 0.9% normal saline used as negative control. All data were treated with t test. Results: All the four complex had anti tumor effect. The inhibition rate of Dpt5-10 and Dpt1-15 on S 180 sarcoma and H 22 solid hepatocarcinoma and the survival prolongation rate of Dpt5-10 on H 22 ascites hepatocarcinoma were similar to those of cisplatin. The toxicity of effective dose of Dpt1-15 was rather high. Conclusions: Cantharidine derivatives and platinum complex is new effective anti tumor drug, among them the Dpt5-10 is the most effective one. Further study for improving the solubility of drug is necessary and study the difference of cross resistance between the new complex and cisplatinum.

关 键 词:斑蝥素衍生物 顺铂 抗癌活性 小鼠 S180肉瘤 

分 类 号:R979.1[医药卫生—药品]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象